Wyeth Pharmaceuticals has asked the Nevada Supreme Court for a new trial over its hormone replacement drugs, arguing Monday that a Reno jury wasn't properly instructed on punitive damages before awarding three women a multimillion-dollar judgment on claims the drugs caused their breast cancer. The lawyer representing the pharmaceutical giant, since acquired by Pfizer, said the jury's "premature" deliberation of punitive damages and comments about Wyeth executives' salaries made by the women's attorneys prejudiced jurors.
Wyeth Seeks New Trial in Nevada Prempro Case
The Associated Press
May 5, 2010